08Jun/20
Government’s Supply of Antiviral Remdesivir Runs Out at End of June
Whatever the supply may be, there may not be enough for everyone who may need it.” Source: VT
25May/20
Antiviral Remdesivir Improves Time to Recovery from COVID-19
Ultimately, the findings support remdesivir as the standard therapy for patients hospitalized with COVID-19 and requiring supplemental oxygen therapy, according to the authors. Source: VT
09May/20
NIH: Begins Clinical Trial of Antiviral Remdesivir and Baricitinib (Anti-Inflammatory) For COVID-19
“We now have solid data showing that remdesivir diminishes to a modest degree the time to recovery for people hospitalized with COVID-19,” said NIAID Director Anthony S. Fauci, M.D. Source: VT